At Mote, we are dedicated to building a scalable, modular, and effective extrahepatic targeted mRNA delivery platform, solving the biggest challenges in extrahepatic delivery field. Our platform has been proven in vivo (in mouse and NHP) to both actively target nanoparticles to cells of interest and prevent uptake in unintended targets.
Address
LexingtonMassachusetts
United States